Compare AdaptHealth Corp (AHCO) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Tencent Music Entertainment Group - ADR — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Tencent Music Entertainment Group - ADR trades at $8.83 (market cap $14.27B). The key difference: Tencent Music Entertainment Group - ADR is far larger — about 10.3× AdaptHealth Corp's market cap, and Tencent Music Entertainment Group - ADR pays a 2.78% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | TME | |
|---|---|---|
Market Cap | $1.38B | $14.27B |
Sector | Health | Media |
52-Week High | $13.38 | $26.36 |
52-Week Low | $8.68 | $8.16 |
Enterprise Value | $3.33B | $11.05B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
TME trades at $8.62, showing slight daily weakness. The stock presents a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported strong revenue growth to $32.90B in 2025 with a robust net income margin of 26.48%, though recent quarterly earnings have missed expectations. Analyst sentiment is divided with a consensus price target of $14.00, representing significant upside potential from current levels.
The investment case for TME hinges on its solid profitability and reasonable valuation multiples, but faces headwinds from competitive pressures and recent earnings misses. Key risks include intensifying competition in China's music streaming market and potential regulatory scrutiny. The consensus view suggests moderate bullishness with the stock trading below analyst targets, though execution on growth initiatives remains critical.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
